2011•Clinical Lymphoma Myeloma & LeukemiaRequires access

5.27 Low-Dose Fludarabine and Cyclophosphamide Combined With Rituximab Is a Safe and Effective Treatment Option for Elderly and Comorbid Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Preliminary Results of Project Q-lite, by the Czech CLL Study Group

Lukáš Smolej, Yvona Brychtová, Martin Špaček, Michael Doubek, David Belada, Monika Motyčková, Eduard Cmunt, Vít Procházka, Peter Rohoň, Hynek Poul, Kateřina Klásková, Tomáš Kozák

Open publisher page 7 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fludarabine, Chronic lymphocytic leukemia, Medicine, Rituximab, Chlorambucil, Cyclophosphamide, Oncology, Internal medicine

Back to paper search Browse research topics Original source

5.27 Low-Dose Fludarabine and Cyclophosphamide Combined With Rituximab Is a Safe and Effective Treatment Option for Elderly and Comorbid Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Preliminary Results of Project Q-lite, by the Czech CLL Study Group — Research Paper | ScholarLens